NCT05674929View on ClinicalTrials.gov

An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 30, 2023

Primary Completion Date

October 2, 2024

Study Completion Date

October 2, 2024

Conditions
Alcohol Use Disorder
Interventions
DRUG

BPL-003

A single dose administered intranasally

Trial Locations (2)

W1G 8DR

Clerkenwell Health, London

Unknown

King's College London, London

Sponsors
All Listed Sponsors
lead

Beckley Psytech Limited

INDUSTRY

NCT05674929 - An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder | Biotech Hunter | Biotech Hunter